BUSINESS● LOW2h ago · Oct 30, 2026, 12:26 PM
AbbVie posts Q3 beat as Skyrizi and Rinvoq offset Humira decline
Seeking Alpha Tech · global
AbbVie reported strong third-quarter earnings, with its drugs Skyrizi and Rinvoq compensating for a decrease in Humira sales. This reflects the company's financial performance and product portfolio dynamics.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoAs energy prices threaten inflation again, Lagarde’s European Central Bank legacy offers lessonsAtlantic CouncilBUSINESS22m agoLiveRamp ticks higher as it's set to be delisted before Monday open on Publicis dealSeeking Alpha Tech